ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $326,000 | -38.1% | 6,291 | -15.0% | 0.01% | -40.0% |
Q1 2022 | $527,000 | +3.9% | 7,399 | +9.1% | 0.01% | -23.1% |
Q4 2021 | $507,000 | +113.9% | 6,779 | +62.6% | 0.01% | +225.0% |
Q3 2021 | $237,000 | -37.8% | 4,169 | -51.9% | 0.00% | -42.9% |
Q2 2021 | $381,000 | +28.3% | 8,664 | +44.1% | 0.01% | +40.0% |
Q1 2021 | $297,000 | -61.1% | 6,012 | -64.0% | 0.01% | -78.3% |
Q3 2020 | $764,000 | -30.5% | 16,698 | -23.8% | 0.02% | -56.6% |
Q2 2020 | $1,100,000 | – | 21,916 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 735,103 | $8,211 | 3.02% |
BRAIDWELL LP | 1,038,310 | $11,597,923 | 0.37% |
ARMISTICE CAPITAL, LLC | 2,100,000 | $23,457,000 | 0.36% |
FARALLON CAPITAL MANAGEMENT LLC | 1,875,000 | $20,943,750 | 0.10% |
PDT Partners, LLC | 67,318 | $751,942 | 0.10% |
Virtus ETF Advisers LLC | 12,784 | $142,797 | 0.09% |
Portland Global Advisors LLC | 34,175 | $382 | 0.06% |
XTX Topco Ltd | 27,222 | $304,070 | 0.05% |
Trexquant Investment LP | 132,561 | $1,480,706 | 0.04% |
SHERBROOKE PARK ADVISERS LLC | 10,100 | $112,817 | 0.04% |